Great Point Partners LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$38.0 - $51.1 $22.9 Million - $30.8 Million
-602,200 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$38.7 - $50.15 $15.6 Million - $20.2 Million
402,200 Added 201.1%
602,200 $27.2 Million
Q4 2017

Feb 14, 2018
BUY
$29.7 - $45.7 $5.94 Million - $9.14 Million
200,000
200,000 $7.87 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email